Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

3.95
Delayed Data
As of Jun 28
 +0.13 / +3.40%
Today’s Change
3.12
Today|||52-Week Range
52.90
-60.62%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close3.82
Today’s open3.86
Day’s range3.84 - 4.18
Volume651,986
Average volume (3 months)818,655
Market cap$139.8M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+5.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+28.45%
P/E ratioNM
Price/Sales30.26
Price/Book0.68

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...+0.30+3.44%
INNLInnocoll Holdings PL...+0.26+5.58%
ARGSArgos Therapeutics I...+0.12+2.23%
CLSDClearside Biomedical...-0.09-1.29%
Data as of 06/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$11.7M
Annual profit (last year)-$83.2M
Net profit margin-711.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Guy MacDonald
Principal Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts

Partner Offers

Search for Jobs